Shares of Verici Dx plc (LON:VRCI – Get Free Report) were down 6.7% on Friday . The company traded as low as GBX 0.35 and last traded at GBX 0.35. Approximately 22,440 shares were traded during trading, a decline of 99% from the average daily volume of 1,715,658 shares. The stock had previously closed at GBX 0.38.
Verici Dx Trading Down 6.7%
The stock has a market cap of £5.30 million, a price-to-earnings ratio of -0.12 and a beta of 1.26. The company has a debt-to-equity ratio of 11.36, a current ratio of 0.91 and a quick ratio of 8.49. The company’s fifty day moving average price is GBX 0.43 and its 200-day moving average price is GBX 0.57.
Verici Dx Company Profile
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Read More
- Five stocks we like better than Verici Dx
- Capri’s Turnaround Is Taking Shape, But Is the Stock a Buy Yet?
- SpaceX Has Real Value—But These 3 Stocks Have Better Odds Right Now
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
